Domain Therapeutics S.A.
Domain Therapeutics is a biopharmaceutical company located in
Strasbourg, France, dedicated to the discovery and early development
of small molecules targeting G-Protein Coupled Receptors (GPCRs),
one of the most important classes of drug targets. Domain
Therapeutics identifies and develops drug candidates using its DTect-All
(TM) innovative proprietary technology. The company’s portfolio is
composed of new chemical entities ranging from hits to optimized
leads for leading indications such as schizophrenia, Parkinson's
disease and diabetes.
www.domaintherapeutics.com
|